Drug Discovery

Personalized Medicine needs Personalized Data

Specialists in Drug Discovering

The whole genome is the most personalized data about a patient. Thanks to our work with patient advocacy groups and leading clinics, we have access to personalized data and to patients. Our drug discovery process starts with the patients’ data.

Often the first concern from patients after they receive a diagnosis through whole genome sequencing is what therapies are available to treat their condition. In an effort to address this issue, Dante Labs decided to create and invest in a drug discovery R&D program.

ANDREA RIPOSATI

Chief Executive Officer

What's next

Clinical Portfolio and Pipeline

We extract information from complex genomic and medical information and transform it into indications to start developing the basis of life-saving therapies.

MULTI-PHASES pipeline

We used our data to launch a drug discovery program. Internal siRNA and mRNA technology applied to rare and common diseases.

Target Discovery

MOLECULE DISCOVERY

NON-REGULATORY PRE-CLINICAL

REGULATORY PRE-CLINICAL

CLINICAL TRIALS

Full internal development

Muscle Rare Disease

Neurological Rare Disease

Oncology mRNA Therapeutic

COVID-19 mRNA Vaccine

Co-development with an external partner

Respiratory

Oncology

What We Do

Full-service Drug Development

Anchored in whole genome sequencing data, Dante’s discovery program supports the development of therapies and drugs, delivering a more personalized, holistic approach to medicine.

Proprietary Sequencing Data

Whole Genome Sequencing of Patient

Dante Machine Learning

Data Analysis in the Dante Platform

Proprietary sequences, targets and molecules

Identification of best drug candidates